CureVac N.V.
CVAC
$5.40
$0.000.00%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 552.75M | 566.88M | 579.37M | 332.71M | 71.21M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 552.75M | 566.88M | 579.37M | 332.71M | 71.21M |
| Cost of Revenue | 28.57M | 69.89M | 114.23M | 150.77M | 164.44M |
| Gross Profit | 524.18M | 496.99M | 465.14M | 181.94M | -93.23M |
| SG&A Expenses | 88.92M | 76.95M | 80.43M | 90.76M | 91.82M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -9.36M | -9.30M | -13.27M | -17.53M | -13.31M |
| Total Operating Expenses | 292.69M | 315.98M | 350.47M | 377.11M | 372.19M |
| Operating Income | 260.06M | 250.90M | 228.90M | -44.40M | -300.99M |
| Income Before Tax | 237.04M | 228.42M | 206.91M | -63.16M | -298.64M |
| Income Tax Expenses | 28.93M | 30.79M | 31.06M | 16.99M | 2.31M |
| Earnings from Continuing Operations | 208.11 | 197.63 | 175.85 | -80.15 | -300.95 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 208.11M | 197.63M | 175.85M | -80.15M | -300.95M |
| EBIT | 260.06M | 250.90M | 228.90M | -44.40M | -300.99M |
| EBITDA | 272.90M | 264.25M | 242.71M | -27.55M | -279.23M |
| EPS Basic | 0.93 | 0.88 | 0.78 | -0.36 | -1.34 |
| Normalized Basic EPS | 0.76 | 0.74 | 0.68 | -0.09 | -0.80 |
| EPS Diluted | 0.93 | 0.88 | 0.78 | -0.36 | -1.34 |
| Normalized Diluted EPS | 0.77 | 0.74 | 0.68 | -0.09 | -0.80 |
| Average Basic Shares Outstanding | 899.23M | 898.40M | 897.60M | 897.45M | 896.91M |
| Average Diluted Shares Outstanding | 906.40M | 900.52M | 899.72M | 899.57M | 899.03M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |